Clinical Evaluation of Tibetan Bloodletting Therapy for Primary Hypertensio
- Conditions
- primary hypertension
- Registration Number
- ITMCTR2100004888
- Lead Sponsor
- Tibetan Medicine Hospital of Dege (Institute of Tibetan Medicine)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. Refer to the Four Medical Codes of Tibetan Medicine and Clinical Diagnosis and Treatment Guidelines for Common Diseases of Tibetan Medicine, and meet the diagnostic criteria of Chalong Shangyi (Anyone with any four of the main syndrome and any two of the concurrent symptoms can be diagnosed as Chalong Shangyi disease:
(1) Main symptoms: dizziness or headache; swelling and heavy head; especially heavy on air congestion, which may be accompanied by difficulty in pitching and difficulty in breathing; tongue examination: tongue is red and rough or white with thick viscous coating; urine examination: the color is blue, and the foam dissipates immediately; pulse examination: the pulse is sudden and smooth;
(2) Concurrent symptoms: purple lips and face, congestion and blue eyes, sometimes stiff neck and hindered movement, especially stinging pain in the shoulders and backs.
2. Refer to the Guidelines for the Prevention and Treatment of Hypertension in China (2018 Revised Edition) and meet the diagnostic criteria for mild and moderate hypertension (mild hypertension: systolic blood pressure 140-159mmHg, diastolic blood pressure 90-99mmHg; moderate hypertension: systolic pressure 160-179mmHg, diastolic pressure 100-109mmHg).
3. Aged 18-65 years.
4. Sign the informed consent form.
1. Secondary hypertension, including renal parenchymal and renovascular hypertension, drug-induced hypertension, and hyperaldosteronism caused by primary hyperaldosteronism, aortic stenosis, obstructive sleep apnea hypopnea syndrome, etc. blood pressure;
2. Combined with diabetes;
3. Combined with serious complications, such as insufficiency of heart, liver and kidney, hematological diseases, malignant tumors, severe infections and mental illnesses, etc.;
4. Pregnant or lactating women;
5. Those who have participated in other clinical research in the past two months.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood pressure;
- Secondary Outcome Measures
Name Time Method 36-item quality of life scale;